- Full text PDF available (3)
- This year (0)
- Last 5 years (2)
- Last 10 years (2)
Journals and Conferences
R&D is arguably that of the unknown — the effects of an investigational drug that you simply can’t predict. But help could be at hand. A paper in Nature Chemical Biology by MacDonald et al. describes… (More)
Drug companies announce streamlining efforts and increase investment in development.
The scope of one of Pfizer’s patents covering atorvastatin, the active ingredient in the company’s blockbuster cholesterol-lowering drug Lipitor, has been upheld by a British Court, but the ruling… (More)
Initiatives to recruit women into academia have recently been launched, but the flexible working environment of biotech and pharma companies is a powerful incentive for luring them away.